ArticleActa parasitologica2025
Expression Analysis of Cyst Specific Protein (CSP21) and Cellulose Synthase II (CSII) Genes in Acanthamoeba castellanii Trophozoites Exposed to Silver Nanoparticles Conjugated with Elaeagnus umbellata.
Article in Acta parasitologica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeAcanthamoeba species are eucaryotic protozoa found predominantly in soil and water. They cause ulceration and vision loss in the cornea (Acanthamoeba keratitis) and central nervous system (CNS) infection involving the lungs (granulomatous amoebic encephalitis). Antiparasitic drugs currently used in the treatment of infections caused by Acanthamoeba species are not effective at the desired level in some anatomical regions such as the eye and CNS. The existence of an agent effective against both cysts and trophozoites has not yet been proven. Drugs used for treatment of Acanthamoeba infrections are still limited.
methodThe present study investigates amoebicidal activites of various concentrations of ethanolic fruit extract of E. umbellata (EU) (40, 20, 10, 5, 2.5, 1.25, 0.625 mM/mL), silver nanoparticles (AgNP) that are synthesized from EU and confirmed with characterization tests (20, 10, 5, 1, 0.5 mM/mL), and lauric acid (LA) in EU detected with gas chromatography-mass spectrometry (GC-MS) against A. castellanii trophozoites. In addition, DNA-preserving activities of EU, AgNP and LA were studied on pBR322 plasmid DNA, following damage induced with hydroxyl radical (-OH). Cytotoxicity of EU over HeLa cells was examined with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT). Furthermore, the effects over the expression of SOD and CAT genes, which are coding oxidative stress enzymes in trophozoites, and expression of genes responsible for pseudocyst and cyst formation (CSII and CSP21, respectively) were investigated following methanol-induced stress, with reverse-transcriptase quantitative polymerase chain reaction (RT-qPCR).
resultsAt highest concentrations, EU, AgNP and LA showed lethal effects against majority of trophozites at 24 th h and against all trophozoites at 48th hour. EU at 5 mg/mL concentration and LA at 1, 0.8, 0.6, 0.4 mM/mL concentrations prevented DNA damage. A dose-dependent decrease in cell viability was observed, EU was found to be non-cytotoxic for 53.82% of HeLa cells at 72 nd h even at 40 mg/mL concentration. Greatest inhibitory effects were found with EU, AgNP and LA on CSII, EU on CAT, LA on CSP21, and hydrogen peroxide (H
conclusionThe findings of this study show that EU, LA and AgNPs can be used in a controlled manner to combat A. castellanii infections by reducing or blocking the activity of the parasite's antioxidant enzymes (SOD and CAT), without giving the parasite a chance to initiate the process of pseudocyst or proper cyst formation.
Indexed as
Identifiers
39760957What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.